| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.9M | — | — |
| Cost of Revenue | $789K | — | — |
| Gross Profit | $3.2M | — | — |
| R&D Expense | $1.6M | — | -24.8% |
| SG&A Expense | $5.7M | — | +6.2% |
| Operating Income | -$9.0M | — | +10.2% |
| Interest Expense | $46K | — | — |
| Pre-tax Income | -$9.1M | — | +8.9% |
| Income Tax | $264K | — | +0.0% |
| Net Income | -$9.4M | — | +8.6% |
| EPS (Basic) | -$0.38 | — | +70.8% |
| EPS (Diluted) | -$0.38 | — | +70.8% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.7M | +81.6% | +601.9% |
| Accounts Receivable | $4.0M | — | — |
| Inventory | $22.6M | +1.6% | +57.4% |
| Current Assets | $37.9M | +35.8% | +107.0% |
| Total Assets | $140.4M | +7.2% | +16.3% |
| Current Liabilities | $38.2M | -14.9% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.0M | — | -175.3% |
| Investing Cash Flow | -$4.4M | — | — |
| Financing Cash Flow | $20.9M | — | +711.1% |
| -14.7% |
| Total Liabilities | $46.9M | -12.1% | -9.4% |
| Stockholders' Equity | $80.0M | +18.4% | +22.2% |